In its first-quarter 2025 investor letter, Baron Health Care Fund highlighted stocks such as Vertex Pharmaceuticals ... you’re backed by our ironclad 30-day money-back guarantee.

The acquisition expands Lilly’s pain pipeline with a slate of drugs targeting ion channel proteins like NaV1.7 and NaV1.8.

After a rough start to the year, small- and mid-cap software stocks may be finding their footing. Goldman Sachs analyst Adam Hotchkiss says first-quarter results across his coverage were better than ...

In a powerful keynote at TiEcon 2025, Vasu Jakkal, Corporate Vice President (CVP) of Security at Microsoft, covered all bases ...

Stakeholders agree that the regulatory overhaul sends a strong signal to both local and international investors, positioning ...

Google has released Gemini 2.5 Pro in preview for select users via Google AI Studio and Vertex AI. The model leads in coding, reasoning, and multilingual benchmarks, offering improved performance.

Big data and AI specialist Palantir Technologies PLTR is gaining significant momentum with its Artificial Intelligence ...

With a better upfront offer on the table, enough bluebird bio investors have tendered their shares for the company's sale to ...

As the U.S. market experiences a slight dip following a strong rally in the S&P 500, investors are closely ... May 19, 2025 (GLOBE NEWSWIRE) -- Vertex Inc. (NASDAQ:VERX) (“Vertex” or the ...

Vertex Minerals Limited (ASX:VTX) announced the early closure of its Share Purchase Plan (SPP) on June 6, 2025, after ...

Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.